{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:55:20Z","timestamp":1758905720779,"version":"3.43.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Acute myeloid leukemia (AML) is a common malignant disorder of the bone marrow, accounting for 23.1% of total leukemia cases globally in 2017. This study aimed to know the prevalence of AML in a tertiary hospital center in Nepal and assess the associated etiological factors in the causation of AML.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods:<\/jats:title>\n            <jats:p>A hospital-based retrospective cross-sectional study was conducted among patients with acute leukemia admitted to a tertiary care center in Kathmandu from 1 April 2021 to 30 April 2022. Three hundred and ten participants with acute leukemia were selected via a convenience sampling technique. The data were entered into Microsoft Excel 365 and then analyzed using Statistical Packages for Social Sciences version 22.0.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>One hundred and forty five (46.7%) out of 310 acute leukemia patients had AML. Most of the cases were male (104, 71.7%) and aged 40\u201349 years (36, 24.8%). The most common signs and symptoms were pallor (115, 79.3%), fever (<jats:italic toggle=\"yes\">n<\/jats:italic>=92, 63.4%), and lethargy\/weakness (78, 53.8%). Ninety one (62.8%) patients underwent multiple cycles of chemotherapy while 51 (35.2%) had supportive care only, and 3 (2.1%) went bone marrow transplants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The prevalence of AML was higher as compared to AML in other studies done in a similar setting. Early diagnosis and treatment are key to a good prognosis and cure in most cases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000001189","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T06:04:13Z","timestamp":1691993053000},"page":"4794-4798","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of acute myeloid leukemia and its associated risk factors at a tertiary care center: a retrospective cross-sectional study"],"prefix":"10.1097","volume":"85","author":[{"given":"Prem S.","family":"Chaurasiya","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kalaiya Provincial Hospital, Bara"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh K.","family":"Lamsal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Civil Service Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"Khatri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Civil Service Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aalok","family":"Parajuli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Civil Service Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prem R.","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Civil Service Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laxmi","family":"Aryal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Burtibang Primary Health Care Center, Baglung, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sapana","family":"Pokhrel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Civil Service Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shekhar","family":"Gurung","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Shivanagar Primary Health Care Center, Chitwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurab","family":"Karki","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Military Hospital Itahari, Sunsari"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0449-9254","authenticated-orcid":false,"given":"Manoj","family":"Khadka","sequence":"additional","affiliation":[{"name":"Nepalese Army Institute of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,10]]},"reference":[{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"35","DOI":"10.31729\/jnma.194","article-title":"Pattern of occurrence of leukemia at a teaching hospital in eastern region of Nepal \u2013 a six year study","volume":"48","author":"Kulshrestha","year":"2009","journal-title":"J Nepal Med Assoc"},{"key":"R5-20250806","article-title":"Leukemia incidence trends at the global, regional, and national level between 1990 and 2017, Exp","volume":"9","author":"Dong","year":"2020","journal-title":"Hematol Oncol"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13045-020-00908-z","article-title":"The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017","volume":"13","author":"Yi","year":"2020","journal-title":"J Hematol Oncol"},{"key":"R7-20250806","first-page":"1","article-title":"The global burden of leukemia and its attributable factors in 204 countries and territories: findings from the global burden of disease 2019 study and projections to 2030","volume":"2022","author":"Du","year":"2022","journal-title":"J Oncol"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"96","author":"Mathew G","year":"2021","journal-title":"Int J Surg"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3126\/jssn.v21i1.24366","article-title":"Spectrum of haematological malignancies managed at tertiary centre: a one-year retrospective review","volume":"21","author":"Shrestha","year":"2018","journal-title":"J Soc Surg Nepal"},{"key":"R10-20250806","first-page":"58","article-title":"Acute myeloid leukemia amongst adults","volume":"2","author":"Asif","year":"2013","journal-title":"J Islam Med Dent Coll"},{"key":"R11-20250806"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3126\/jnps.v34i1.9056","article-title":"Acute lymphoblastic leukemia: fourteen years experience of a single institution","volume":"34","author":"Sah","year":"2014","journal-title":"J Nepal Paediatr Soc"},{"key":"R13-20250806","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","article-title":"Advances in the treatment of acute myeloid leukemia: new drugs and new challenges","volume":"10","author":"Short","year":"2020","journal-title":"Cancer Discov"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","article-title":"Emerging agents and regimens for AML","volume":"14","author":"Liu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/2014152","article-title":"Prevalence of leukemia and associated factors among patients with abnormal hematological parameters in jimma medical center, Southwest Ethiopia: a cross-sectional study","volume":"2020","author":"Kassahun","year":"2020","journal-title":"Adv Hematol"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000001189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:19:04Z","timestamp":1754486344000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000001189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":13,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000001189","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"electronic","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"2023-04-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}